Toxicities with targeted therapies after immunotherapy in metastatic melanoma

por Grogan, Nicole, Swami, Umang, Bossler, Aaron D., Zakharia, Yousef, Milhem, Mohammed
Publicado no Melanoma Res (2018)

Urothelial carcinoma with an NRF1-BRAF rearrangement and response to targeted therapy

por Isaacson, Alexandra L., Guseva, Natalya V., Bossler, Aaron D., Ma, Deqin
Publicado no Cold Spring Harb Mol Case Stud (2019)

Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events

por Swami, Umang, Monga, Varun, Bossler, Aaron D., Zakharia, Yousef, Milhem, Mohammed
Publicado no J Oncol (2019)

CLIA Laboratory Testing for Facioscapulohumeral Dystrophy: A Retrospective Analysis

por Rieken, Autumn, Bossler, Aaron D., Mathews, Katherine D., Moore, Steven A.
Publicado no Neurology (2021)

BCR-NTRK2 fusion in a low-grade glioma with distinctive morphology and unexpected aggressive behavior

por Jones, Karra A., Bossler, Aaron D., Bellizzi, Andrew M., Snow, Anthony N.
Publicado no Cold Spring Harb Mol Case Stud (2019)

A simple and cost-effective method of DNA extraction from small formalin-fixed paraffin-embedded tissue for molecular oncologic testing

por Snow, Anthony N, Stence, Aaron A, Pruessner, Jonathan A, Bossler, Aaron D, Ma, Deqin
Publicado em 2014

Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma

por Swami, Umang, Monga, Varun, Freesmeier, Michele, Zhang, Weizhou, Bossler, Aaron D., Zakharia, Yousef, Milhem, Mohammed
Publicado no Melanoma Res (2019)

Muscle-Eye-Brain Disease

por Shenoy, Anant M., Markowitz, Jennifer A., Bonnemann, Carsten G., Krishnamoorthy, Kalpathy, Bossler, Aaron D., Tseng, Brian S.
Publicado em 2010

A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas

por Monga, Varun, Swami, Umang, Tanas, Munir, Bossler, Aaron, Mott, Sarah L., Smith, Brian J., Milhem, Mohammed
Publicado no Cancers (Basel) (2018)

Multivariable Analysis of 169 Cases of Advanced Cutaneous Melanoma to Evaluate Antibiotic Exposure as Predictor of Survival to Anti-PD-1 Based Immunotherapies

por Swami, Umang, Chennamadhavuni, Adithya, Borcherding, Nicholas, Bossler, Aaron D., Mott, Sarah L., Garje, Rohan, Zakharia, Yousef, Milhem, Mohammed
Publicado no Antibiotics (Basel) (2020)

Genomic Sequencing Procedure Microcosting Analysis and Health Economic Cost-Impact Analysis: A Report of the Association for Molecular Pathology

por Sabatini, Linda M., Mathews, Charles, Ptak, Devon, Doshi, Shivang, Tynan, Katherine, Hegde, Madhuri R., Burke, Tara L., Bossler, Aaron D.
Publicado no J Mol Diagn (2016)

Leukemic Transdifferentiation of Follicular Lymphoma Into an Acute Histiocytic Leukemia in a 52-Year-Old Caucasian Woman

por Steussy, Bryan, Lekostaj, Jacqueline, Qian, Qining, Rosenthal, Nancy, Holman, Carol J., Syrbu, Sergei, Darbro, Benjamin, Bossler, Aaron, Karandikar, Nitin J.
Publicado no Lab Med (2016)

Human Papillomavirus (HPV) Type 18 Induces Extended Growth in Primary Human Cervical, Tonsillar, or Foreskin Keratinocytes More Effectively than Other High-Risk Mucosal HPVs

por Lace, Michael J., Anson, James R., Klingelhutz, Aloysius J., Lee, John H., Bossler, Aaron D., Haugen, Thomas H., Turek, Lubomir P.
Publicado em 2009

RARE-13. INFLAMMATORY MYOFIBROBLASTIC TUMOR MIMICKING DESMOPLASTIC INFANTILE GANGLIOGLIOMA (DIG) OF THE TEMPORAL LOBE

por Abukhiran, Ibrahim, Lora, Gino Bardi, Kirby, Patricia, Shelton, Julia, Shilyanski, Joel, Wilson, Saul, Bossler, Aaron, Sato, Yutaka, Bashir, Amani, Sato, Mariko
Publicado no Neuro Oncol (2020)

Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1

por Lace, Michael J., Anson, James R., Klingelhutz, Aloysius J., Harada, Hisashi, Taniguchi, Tadatsugu, Bossler, Aaron D., Haugen, Thomas H., Turek, Lubomir P.
Publicado no Carcinogenesis (2009)

DELETION OF THE PDZ MOTIF OF HPV16 E6 PREVENTING IMMORTALIZATION AND ANCHORAGE-INDEPENDENT GROWTH IN HUMAN TONSIL EPITHELIAL CELLS

por Spanos, William C., Geiger, Jeremy, Anderson, Mary E., Harris, George F., Bossler, Aaron D., Smith, Russell B., Klingelhutz, Aloysius J., Lee, John H.
Publicado em 2008

Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study

por Zakharia, Yousef, Monga, Varun, Swami, Umang, Bossler, Aaron D., Freesmeier, Michele, Frees, Melanie, Khan, Mirza, Frydenlund, Noah, Srikantha, Rithu, Vanneste, Marion, Henry, Michael, Milhem, Mohammed
Publicado no Oncotarget (2017)

The PDZ Binding Motif of Human Papillomavirus Type 16 E6 Induces PTPN13 Loss, Which Allows Anchorage-Independent Growth and Synergizes with Ras for Invasive Growth

por Spanos, William C., Hoover, Andrew, Harris, George F., Wu, Shu, Strand, Guinevere L., Anderson, Mary E., Klingelhutz, Aloysius J., Hendriks, Wiljan, Bossler, Aaron D., Lee, John H.
Publicado em 2008

Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

por Brogden, Kim A., Parashar, Deepak, Hallier, Andrea R., Braun, Terry, Qian, Fang, Rizvi, Naiyer A., Bossler, Aaron D., Milhem, Mohammed M., Chan, Timothy A., Abbasi, Taher, Vali, Shireen
Publicado no BMC Cancer (2018)

Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

por Brogden, Kim A., Parashar, Deepak, Hallier, Andrea R., Braun, Terry, Qian, Fang, Rizvi, Naiyer A., Bossler, Aaron D., Milhem, Mohammed M., Chan, Timothy A., Abbasi, Taher, Vali, Shireen
Publicado no BMC Cancer (2018)